How many acquisitions has Ipsen made so far?

Ipsen has completed 9 acquisitions so far, with an average acquisition amount of $494M.

Which countries does Ipsen usually acquire in?

Ipsen has made acquisitions in 6 countries with the most activity in United Kingdom and United States.

In which year did Ipsen make the most acquisitions?

Ipsen was most active in 2015, with 2 acquisitions completed in that year.

List of 9 Acquisitions by Ipsen (Apr 2026)

Q: Which is Ipsen's latest acquisition?

Ipsen's most recent acquisition is Imcheck Therapeutics, a Developer of immunotherapeutic antibodies for the treatment of multiple diseases, acquired in December 2025.

Most viewed in 2019

Ipsen has made a total of 9 acquisitions. Peak acquisition years include 2015 with 2 acquisitions, and 2025 and 2023 each with 1 acquisition. Its acquisition activity spans 6 countries, including United Kingdom (3), United States (2), and France (1). The company has also engaged in acquisitions across 8 sectors, prominently in Oncology (4), Genomics (1), and Neurology (1). Over the last five years (2020–2025), it has averaged 0.6 acquisitions per year, and in the current calendar year, 0 acquisitions have been completed so far. The most recent acquisition was Imcheck Therapeutics, a developer of immunotherapeutic antibodies for treating multiple diseases. Founded in 2015 and based in Marseille, this acquisition was completed in December, 2025.

Here's the year on year acquisition history of Ipsen:

Number of Total Acquisitions

Year	# Acquisitions
2025	1
2023	1
2022	1
2019	1
2017	1
2015	2
2013	1
2008	1

View all Acquisitions by Ipsen

Recent acquisitions by Ipsen

Ipsen's most recent acquisition - Imcheck Therapeutics is a Developer of immunotherapeutic antibodies for the treatment of multiple diseases, founded in 2015 and located in Marseille. Ipsen acquired it in December 2025 for a price of $*****.

Here is the list of all acquisitions by Ipsen sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Dec 15, 2025	Imcheck Therapeutics	was{	eqti	22	785
Jan 09, 2023	Albireo Pharma	dagl	sgl{	27	899
Jun 27, 2022	Epizyme	ev{y	acok	39	131
Feb 25, 2019	Clementia	gpsr	msee	13	221
Jan 08, 2017	ONIVYDE	ezli	asyo	58	813